← Leaderboards
Sarah George
Saint Louis University
$2,187,945
Attributed
$2,187,945
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,187,945 · 1
By mechanism
N01$2,187,945 · 1
Top collaborators
No co-investigators on record.
Most similar at Saint Louis University
Same institution · by research overlap
- Daniel Hoft$14,766,530
- Robert B. Belshe$24,085,110
- Daniel F. Hoft$50,608,486
- Brent A Neuschwander-Tetri$12,806,115
- Ranjit Ray$8,996,397
Others in their field
Top investigators on “Combat”
- Thomas William Geisbert · Boston University Medical Campus$53,901,766
- Alan A Aderem · University Of Washington$34,302,157
- Alpha Albert Lee · Sloan-Kettering Inst Can Research$33,555,942
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,555,942
- Howard Fishbein · Battelle Centers/Pub Hlth Res & Evaluatn$29,828,069
- Jenny P.y. Ting · Univ Of North Carolina Chapel Hill$25,952,988
Research focus
CombatCommunicable DiseasesConduct Clinical TrialsContractsDesignPhase I Clinical TrialsProgramsResourcesVaccinesEvaluationVaccine CandidateZika Virus VaccineZika VirusNamed GroupSpecial PopulationVaccine Trial
Grant awards (3)
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Zika Vaccine Candidate$726,955
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Zika Vaccine Candidate$113,642
N01 · FY2022 · AI · contact PI
VTEU: PHASE I ZIKA VIRUS VACCINE TRIALS$1,347,348
N01 · FY2016 · AI · contact PI